Letter Regarding the Article, &Ldquo;A Randomized, Double-Blind Clinical Trial of Canrenone vs Hydrochlorothiazide in Addition to Angiotensin II Receptor Blockers in Hypertensive Type 2 Diabetic Patients”
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s185297
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Informa UK Limited